USMLE® Step 2 CK · Cardiovascular / Cardiology · Topic CV-PREV-01
Lipids & ASCVD risk reduction
Lipids & ASCVD risk reduction (CV-PREV-01) in USMLE® Step 2 CK Cardiovascular / Cardiology (USMLE® Step 2 CK Review Book p. 178). Guideline basis: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Dyslipidemia; 2022 ACC Expert Consensus Decision Pathway nonstatin therapies. Covers: Primary prevention risk and statin indications, Statin intensity and LDL targets, Non-statin add-on sequence, Statin myopathy and drug interactions. Practice 28 QuestionBank questions, ChartWalk bedside clinical algorithms, FlashCards, and ImageBank on TheCodexes.com. Understand beyond your boards.
- Topic Code
- CV-PREV-01
- Chapter
- Cardiovascular / Cardiology
- Review Book Page
- p. 178
- QuestionBank Items
- 28 questions
Primary Guideline / Source: 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Dyslipidemia; 2022 ACC Expert Consensus Decision Pathway nonstatin therapies
Key Clinical Sections
- Primary prevention risk and statin indications
- Statin intensity and LDL targets
- Non-statin add-on sequence
- Statin myopathy and drug interactions
- Familial hypercholesterolemia